usamicro_0048|PHAS|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment|price_next_month|price_second_month
usamicro_0048|PHAS|1|PhaseBio Pharmaceuticals Inc Total Current Assets (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Cash and Short Term Investments (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Inventories (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Net PP&E (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Goodwill and Intangibles (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Total Liabilities (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Total Current Liabilities (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Total Long Term Liabilities (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Total Deposits (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Book Value (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Retained Earnings (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Treasury Stock (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc EV to Revenues|PhaseBio Pharmaceuticals Inc EV to Earnings|PhaseBio Pharmaceuticals Inc EV to Free Cash Flow|PhaseBio Pharmaceuticals Inc EV to Assets (Quarterly)|PhaseBio Pharmaceuticals Inc PS Ratio|PhaseBio Pharmaceuticals Inc PE Ratio|PhaseBio Pharmaceuticals Inc Price to Book Value|PhaseBio Pharmaceuticals Inc PEG Ratio|PhaseBio Pharmaceuticals Inc Debt to Equity Ratio|PhaseBio Pharmaceuticals Inc Dividend Yield|PhaseBio Pharmaceuticals Inc Shareholder Yield (TTM)|PhaseBio Pharmaceuticals Inc Percent of Shares Outstanding Short|PhaseBio Pharmaceuticals Inc Total Receivables (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Total Payables (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Total Capital Stock (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Return on Invested Capital|PhaseBio Pharmaceuticals Inc Quality Ratio Score|PhaseBio Pharmaceuticals Inc Momentum Score|PhaseBio Pharmaceuticals Inc Beta (1Y)|PhaseBio Pharmaceuticals Inc Sustainable Growth Rate (TTM)|PhaseBio Pharmaceuticals Inc Institutional Investor Ownership Percentage|PhaseBio Pharmaceuticals Inc Average Diluted Shares Outstanding (Quarterly)|PhaseBio Pharmaceuticals Inc Total Employees (Annual)|PhaseBio Pharmaceuticals Inc EPS Diluted (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc SG&A Expense (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Shares Outstanding|PhaseBio Pharmaceuticals Inc Repurchase of Capital Stock (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Ordinary Shares Number (Quarterly)|PhaseBio Pharmaceuticals Inc Payout Ratio|PhaseBio Pharmaceuticals Inc Quick Ratio (Quarterly)|PhaseBio Pharmaceuticals Inc Normalized Diluted EPS (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Stock Buybacks (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Effective Tax Rate (TTM)|PhaseBio Pharmaceuticals Inc Return on Equity|PhaseBio Pharmaceuticals Inc Net Income (TTM) (USD)|PhaseBio Pharmaceuticals Inc Revenue (TTM) (USD)|PhaseBio Pharmaceuticals Inc Dividend Per Share (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Revenue (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Gross Profit (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Pre-Tax Income (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Net Income (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Net Interest Income (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Price (USD)|PhaseBio Pharmaceuticals Inc Total Return Price (USD)|PhaseBio Pharmaceuticals Inc Enterprise Value (USD)|PhaseBio Pharmaceuticals Inc 30-Day Average Daily Volume|PhaseBio Pharmaceuticals Inc 1 Year Price Returns (Daily)|PhaseBio Pharmaceuticals Inc Short Interest|PhaseBio Pharmaceuticals Inc PE Ratio (Forward)|PhaseBio Pharmaceuticals Inc PE Ratio (Forward 1y)|PhaseBio Pharmaceuticals Inc PS Ratio (Forward)|PhaseBio Pharmaceuticals Inc PS Ratio (Forward 1y)|PhaseBio Pharmaceuticals Inc Quarterly EPS Estimates (USD)|PhaseBio Pharmaceuticals Inc Quarterly Revenue Estimates (USD)|PhaseBio Pharmaceuticals Inc Quarterly EPS Surprise|PhaseBio Pharmaceuticals Inc Quarterly Revenue Surprise|PhaseBio Pharmaceuticals Inc Quarterly Actual EPS (USD)|PhaseBio Pharmaceuticals Inc Quarterly Actual Revenue (USD)|PhaseBio Pharmaceuticals Inc Revenue Estimates for Current Fiscal Year (USD)|PhaseBio Pharmaceuticals Inc Revenue Estimates for Next Fiscal Year (USD)|PhaseBio Pharmaceuticals Inc Price Target (USD)|PhaseBio Pharmaceuticals Inc Consensus Recommendation|PhaseBio Pharmaceuticals Inc Price Target Num Estimates|PhaseBio Pharmaceuticals Inc EPS Estimates for Current Fiscal Year (USD)|PhaseBio Pharmaceuticals Inc EPS Estimates for Next Fiscal Year (USD)|PhaseBio Pharmaceuticals Inc Research and Development Expense (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Reconciled Depreciation (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Non-Operating Interest Expense (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Land and Improvements (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Buildings and Improvements (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Other Properties (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Machine, Furniture & Equipment (Quarterly) (USD)||
usamicro_0048|PHAS|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
usamicro_0048|PHAS|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|monthly|daily|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|monthly|quarterly|quarterly|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
usamicro_0048|PHAS|5|97.7857142857|97.7857142857||97.7857142857||97.7857142857|97.7857142857|97.7857142857||97.7857142857|97.7857142857|97.7857142857||91.375|6.98170731707|91.2727272727|||7.00769230769|1.44571428571|91.2727272727|1.45065398335|91.375|15.2307692308|98.2307692308|97.7857142857|97.7857142857|91.2857142857||31.72|30.4814814815|91.3333333333|30.5|91.3125|105.307692308|91.3125|91.3125|36.4516129032||97.7857142857|91.375|91.2727272727|91.3125|91.3846153846||91.3333333333|91.3846153846|||91.2727272727||91.3125|91.3125|91.3125|6.97142857143|6.97142857143|6.97142857143|6.92941176471|1.44915254237|15.2307692308|||1.44712430427|1.44712430427|91.3846153846|91.3846153846|91.375|91.375|91.375|91.375|25.6341463415|38.2580645161|42.9259259259|13.7906976744|42.9259259259|20.6078431373|22.3773584906|91.3125|91.3125|91.3125|||97.7857142857|97.7857142857||
usamicro_0048|PHAS|6|14|14||14||14|14|14||14|14|14||8|164|11|||130|350|11|841|8|78|13|14|14|7||25|27|6|14|16|13|16|16|31||14|8|11|16|13||6|13|||11||16|16|16|175|175|175|170|590|78|||539|539|13|13|8|8|8|8|41|31|27|86|27|51|53|16|16|16|||14|14||
usamicro_0048|PHAS|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
usamicro_0048|PHAS|201709||||||||||||||||||||||||||||||||||12.3923||-0.2066|0.565||||||-0.2017|||||||||-2.56|-2.56|-0.604||||||||||||||||||||||||1.33|0.028|0.618||||||
usamicro_0048|PHAS|201712|13.766|13.406||0.302||111.515|17.595|93.92||-97.416|-99.065|0.024||||||||||||||0.43|0.001|||||||12.3923|18|-0.2046|0.628|||19.5884|||-0.2861|||||||||-2.535|-2.535|-1.095||||||||||||||||||||||||1.823|0.028|1.118|||1.681|0.244||
usamicro_0048|PHAS|201803||||||||||||||||||||||||||||||||||12.3923||-0.3553|0.643||||||-0.3426|||||||||-4.403|-4.403|-1.368||||||||||||||||||||||||2.235|0.027|1.404||||||
usamicro_0048|PHAS|201806|28.664|28.446||0.276||9.247|5.117|4.13||20.354|-110.142|0.024||||||||||||||0.569|0.015|||||||19.5884||-0.3407|0.917|||19.5884|||-0.2817||||-16.172|||||-6.674|-6.674|-1.411||||||||||||||||||||||||3.19|0.027|1.447|||1.684|0.269||
usamicro_0048|PHAS|201809|24.968|24.341||0.251||143.662|7.688|135.974||-116.174|-118.043|0.024||||||||||||0.0171|0.411|1.576|0.001|||||||19.5884|19|-0.4034|1.056|23.8038||19.5884|||-0.2976||||-21.513|||||-7.901|-7.901|-0.83|5.1|5.1|104.5584|120362.8667||4063|||||||||||||16.6667|1.25|3||-1.3163|4.354|0.028|0.89|||1.684|0.27|2.92|
usamicro_0048|PHAS|201812|62.628|61.031||0.355||12.099|4.577|7.522||50.927|-122.911|0.024|||-1.291|0.3517|||1.4864||0.1473|||0.163|0.233|1.806|0.025|||||||24.4983|24|-0.26|2.241|24.4983||24.4983||13.3852|-0.371|-42.974|||-23.846|||0.668||-4.868|-4.868|0.072|3.1|3.1|59.1037|50104.8333||39942||||||||||||||1.25|||-1.2184|5.676|0.023|0.183|||1.764|0.326|3.3|3.1589
usamicro_0048|PHAS|201903|54.075|51.894||2.279||12.304|3.797|8.507||44.082|-130.204|0.024|||-9.8652|3.3404|||4.3775||0.1648|||0.5959|0.67|2.058|0.025|||||||24.4984|27|-0.3|2.316|24.4984||24.4984||13.8436|-0.3||||-26.736|||0.653||-7.293|-7.293|0.091|8.66|8.66|169.4044|326750.5667||145995|||||||||||0.1933||21.6667|1.25|3|-1.755|-1.7509|5.721|0.031|0.226|||3.68|0.351|13.75|11.56
usamicro_0048|PHAS|201906|94.897|90.342||2.509||15.829|5.746|10.083||81.609|-139.436|0.024|||-13.3172|3.0364|||8.0656||0.1188|||1.9965|1.18|3.047|0.029|||||||27.9326|30|-0.33|2.404|28.6976||28.6976||15.9279|-0.3292|-46.308|||-29.294|||0.703||-9.232|-9.232|0.272|12.42|12.42|310.9173|173408.2667||571524|||||||||||1.022|0.6667|22.3333|1.25|3|-1.3702|-1.6723|7.781|0.043|0.219|||3.92|0.371|8.28|8.07
usamicro_0048|PHAS|201909|83.369|81.771||2.802||15.399|5.962|9.437||70.804|-150.827|0.024||-1.4598|-1.0592|0.5552|||1.375||0.1374||-74.7673|6.1067|0.583|1.659|0.029|-46.5665||4|1.3782|-124.8933||28.7199|32|-0.4|2.803|28.7528||28.7528||13.8131|-0.4005|0.031||-124.8933|-32.784|||||-11.391|-11.391|0.185|3.91|3.91|31.5643|181129.9667|-19.4118|1755849|||||-0.3642|0.1806|-9.8207|33.4441|-0.4|0.241|1.7295|0.5|20.6667|1.2|3|-1.4032|-1.7842|9.028|0.05|0.266|||3.885|0.377|4.2|3.24
usamicro_0048|PHAS|201912|78.823|74.025||3.639||22.516|8.479|14.037||59.978|-162.158|0.024||-2.9669|-2.8713|1.4115|||2.9305||0.2452||-27.0299|7.9501|1.233|2.921|0.029|-55.077||7|2.1834|-63.837||28.7769|40|-0.39|3.663|28.7664||28.7664||8.8758|-0.3897|||-63.837|-39.247|||1.861||-11.331|-11.331|-0.042|6.11|6.11|116.4417|576613.2|97.7346|2286969|||593.7929|16.7154|-0.395|0.1982|-1.2735|285.4692|-0.4|0.764|1.7958|0.6758||1.3333||-1.4248|-1.8312|8.381|0.05|0.365|||3.827|0.386|5.26|4.33
usamicro_0048|PHAS|202003|72.541|59.441||4.285||23.372|7.495|15.877||53.486|-177.063|0.024||-1.0791|-0.8994|0.6579|||1.6315||0.2757||-50.0986|9.612|0.896|1.918|0.029|-63.9984||9|2.2926|-75.589||28.7733|40|-0.52|3.159|28.7806||28.7806||8.0503|-0.5044|||-75.589|-46.859|||0.32||-14.905|-14.905|-0.167|3.31|3.31|50.5668|304164.2|-65.1945|2766402|||321.8371|9.0598|-0.4212|2.2108|-23.448|-85.5256|-0.52|0.32|8.0728|11.4462|18.75|1.3333|4|-1.9432|-2.5523|11.449|0.054|0.378|||3.833|0.386|3.74|4.49
usamicro_0048|PHAS|202006|63.741|53.025||7.012||44.417|17.802|26.615||26.393|-205.205|0.024||-1.4372|-1.7116|1.3349|||5.0302||0.5601||-1.4649|10.8621||6.967|0.029|-92.3917||3|1.9495|-112.5141||28.8052|50|-0.98|3.242|28.8616||28.8616||2.9786|-0.852|-0.472||-112.5141|-65.769|||||-28.142|-28.142|-0.358|4.6|4.6|94.5214|1221574.7333|-64.939|3134958|||448.5249|12.6261|-0.5167|0.1304|-89.6835|-100|-0.98||0.9086|0.784|16.6667|1.4|3|-2.005|-2.32|20.856|0.057|0.379|||4.391|0.386|4.38|3.8
usamicro_0048|PHAS|202009|49.948|39.353||8.202||53.855|11.37|42.485||4.352|-230.348|0.024||-0.9703|-1.1566|1.3255|||3.869|-0.0113|3.0924||-3.5854|13.032||2.124|0.029|-140.779||2|1.7528|-184.9214|74.5497|29.2432|50|-0.86|3.076|29.3593||29.3593||3.4611|-0.7132|-2.47||-184.9214|-79.521|||||-25.143|-25.143|-0.359|3.48|3.48|63.8713|247177.4333|-15.8273|3826095|||348.1458|9.8004|-0.8347|0.14|-3.0261|-100|-0.86||0.538|0.3532||1.3333||-3.0512|-2.6471|17.416|0.055|0.362|||4.147|0.247|2.85|3.57
usamicro_0048|PHAS|202012|40.149|28.122||10.151||75.559|14.96|60.599||-25.202|-260.723|0.024||-0.8414|-1.1157|1.6469|||21.9966|-0.0071|-0.4812||-3.4588|8.012||3.674|0.029|-260.997||7|2.0217|-414.1143|75.721|29.4002|50|-1.03|3.611|29.4419||29.4419||1.8798|-0.8915|||-414.1143|-98.565|||0.32||-30.375|-30.375|-0.324|3.26|3.26|69.8342|316419.9667|-45.0082|2358891|||9.408|6.5731|-0.6977|0.048|-47.6258|-100|-1.03||0.296||13.5|1.3333|4|-3.0512|-2.4671|22.367|0.342|0.326|||10.921|0.247|4.12|4.02
usamicro_0048|PHAS|202103|88.157|76.963||12.607||92.41|16.668|75.742||8.411|-288.081|0.024||-0.8985|-2.2731|0.9893|||17.3314|-0.0072|1.2834||-37.7884|6.7419||5.898|0.048|-416.2717||2|2.2567|-823.0872|91.4481|31.2827|50|-0.87|3.327|47.952||47.952||4.6174|-0.8244|-60.536||-823.0872|-111.018|||||-27.358|-27.358|-0.283|3.25|3.25|139.4964|887931.9|4.5317|3232883|||15.7788|11.0242|-0.695|0.016|-25.1799|-100|-0.87||0.0768|6.3244|15|1.4|3|-2.78|-2.815|22.32|0.474|0.285|||13.65|0.247|3.04|3.11
usamicro_0048|PHAS|202106|88.5|64.456||12.08||119.812|16.174|103.638||-19.175|-316.76|0.024||-1.1086|-2.3258|1.2288|||20.9231|-0.0237|-0.4932||-34.5698|7.2807|18.4|2.958|0.048|-1006.8141||1|1.5517||92.1967|47.9859|55|-0.6|4.025|48.0278||48.0278||5.1228|-0.5121|0.185|||-111.555|||10.338||-27.079|-28.679|-0.249|3.67|3.67|109.8158|387308.5|-19.1304|3496757|||16.9913|11.8713|-0.4267|5.02|-40.6239|105.9363|-0.6|10.338|4.0672|12.4675|12.75|1.4|4|-2.26|-2.205|27.366|0.583|0.254|||13.945|0.254|3.51|3.24
usamicro_0048|PHAS|202109|65.241|56.357||12.427||128.054|21.457|106.597||-50.329|-348.684|0.024||-0.8555|-1.8943|1.3025||||-0.066|-0.1613||-39.4735|4.4123||8.521|0.048|||2|1.8365||96.2456|48.0463|60|-0.66|3.845|48.0625||48.0625||2.6265|-0.5949|0.015|||-118.336|||0.335||-31.924|-31.924|-0.218|3.08|3.08|92.9719|343389.4333|-11.396|2120647|||14.2153|9.9319|-0.5933|1.0662|-11.2366|-68.58|-0.66|0.335|10.7683|15.924|14.5|1.5|4|-2.6833|-2.0633|25.066|0.13|0.222|||14.405|0.369|3.85|2.08
usamicro_0048|PHAS|202112|||||||||||||||-1.9515|||||-0.0554||||9.7439||||||2|1.6356||92.6089||||||||||||||||||||||2.62|2.62|77.7558|641615.6667|-22.3214|4685862|||8.3399|4.4078|-0.645|1.966|||||10.515|15.05|16|1.4|3|-2.72|-2.2833||||||||2.1|1.31
usamicro_0048|PHAS|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.57|||||||||||||||||||||
usamicro_0048|PHAS|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.55|||||||||||||||||||||
usamicro_0048|PHAS|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.5|10||||||||||||||||||||
usamicro_0048|PHAS|202212|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.49|8.1667||||||||||||||||||||